Celanese (CE)
(Real Time Quote from BATS)
$137.52 USD
+0.62 (0.45%)
Updated Jul 26, 2024 09:44 AM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Brokerage Reports
Celanese Corporation [CE]
Reports for Purchase
Showing records 141 - 160 ( 474 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
1Q Follow Up: Near-Term Setup Likely Needs M&A to Drive Further Upside
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
1Q21 First Look - ''21 Guide Raised Again; Beating in Specialties and Commodity Acetyls
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: Expect Further Upside to Chemicals in 2021; Upgrade WLK to Overweight
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Strong Outlook Following 2021 Investor Day; We Raise Our Price Target to $183
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Guiding Higher on Strong Acetyls, EM Demand; Organic Expansions Pick Up Pace, a Positive, in Our View
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
4Q20 Follow-Up - Acetyls Remain Tight; Watching EM Margins in 2021
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department